Immunome Inc. monthly returns
Immunome Inc. has averaged 5.40% per month, positive in 46% of months. Month-by-month returns for Immunome Inc. (IMNM) below, through October 16, 2026 — the table lists the most recent months; the bar chart plots the last 5 years.
Immunome Inc. monthly returns#
| Month | Path | Total return |
|---|---|---|
| Oct 2026 | -23.4% | |
| Sep 2026 | -21.5% | |
| Aug 2026 | +20.4% | |
| Jul 2026 | +7.4% | |
| Jun 2026 | -2.9% | |
| May 2026 | -4.8% | |
| Apr 2026 | +4.9% | |
| Mar 2026 | +0.0% | |
| Feb 2026 | -11.2% | |
| Jan 2026 | +14.6% | |
| Dec 2025 | +16.6% | |
| Nov 2025 | +14.6% | |
| Oct 2025 | +37.2% | |
| Sep 2025 | +23.1% | |
| Aug 2025 | -9.6% | |
| Jul 2025 | +13.1% | |
| Jun 2025 | +6.2% | |
| May 2025 | -0.3% | |
| Apr 2025 | +30.6% | |
| Mar 2025 | -28.4% | |
| Feb 2025 | -14.8% | |
| Jan 2025 | +3.9% | |
| Dec 2024 | -21.6% | |
| Nov 2024 | +18.1% | |
| Oct 2024 | -21.5% | |
| Sep 2024 | -3.7% | |
| Aug 2024 | -1.5% | |
| Jul 2024 | +27.4% | |
| Jun 2024 | -19.0% | |
| May 2024 | +6.3% | |
| Apr 2024 | -43.0% | |
| Mar 2024 | +2.0% | |
| Feb 2024 | +46.0% | |
| Jan 2024 | +54.9% | |
| Dec 2023 | +43.4% | |
| Nov 2023 | -15.2% | |
| Oct 2023 | +5.4% | |
| Sep 2023 | +29.5% | |
| Aug 2023 | -9.9% | |
| Jul 2023 | -9.5% | |
| Jun 2023 | +51.0% | |
| May 2023 | +9.4% | |
| Apr 2023 | -4.0% | |
| Mar 2023 | +9.2% | |
| Feb 2023 | -13.6% | |
| Jan 2023 | +139.4% | |
| Dec 2022 | -48.9% | |
| Nov 2022 | -0.8% | |
| Oct 2022 | -1.8% | |
| Sep 2022 | -22.6% | |
| Aug 2022 | +47.7% | |
| Jul 2022 | +21.0% | |
| Jun 2022 | -17.5% | |
| May 2022 | +3.5% | |
| Apr 2022 | -33.8% | |
| Mar 2022 | -13.7% | |
| Feb 2022 | -26.6% | |
| Jan 2022 | -30.9% | |
| Dec 2021 | -31.6% | |
| Nov 2021 | -19.2% | |
| Oct 2021 | -3.7% | |
| Sep 2021 | +73.6% | |
| Aug 2021 | -13.5% | |
| Jul 2021 | -6.2% | |
| Jun 2021 | -17.3% | |
| May 2021 | -21.2% | |
| Apr 2021 | -21.6% | |
| Mar 2021 | -14.4% | |
| Feb 2021 | +172.4% | |
| Jan 2021 | +50.1% | |
| Dec 2020 | -13.6% | |
| Nov 2020 | -1.3% |
Monthly total return (since Nov 2021)#
Immunome Inc. returns by calendar month#
Every month of every year since 2021, one tick per year on a shared scale; the dark bar is the month's average. Total returns, dividends reinvested.
October 2026 so far: -23.43% — 6th of 6 Octobers since 2021 at the last close; the average October returned +3.1%.
| Month | −175%0+175% | Average | Median | Up | Best | Worst |
|---|---|---|---|---|---|---|
| Jan | +38.7% | +32.4% | 83% | +139.4% 2023 | -30.9% 2022 | |
| Feb | +25.4% | -12.4% | 33% | +172.4% 2021 | -26.6% 2022 | |
| Mar | -7.5% | -6.8% | 50% | +9.2% 2023 | -28.4% 2025 | |
| Apr | -11.2% | -12.8% | 33% | +30.6% 2025 | -43.0% 2024 | |
| May | -1.2% | +1.6% | 50% | +9.4% 2023 | -21.2% 2021 | |
| Jun | +0.1% | -10.1% | 33% | +51.0% 2023 | -19.0% 2024 | |
| Jul | +8.9% | +10.3% | 67% | +27.4% 2024 | -9.5% 2023 | |
| Aug | +5.6% | -5.5% | 33% | +47.7% 2022 | -13.5% 2021 | |
| Sep | +13.0% | +9.7% | 50% | +73.6% 2021 | -22.6% 2022 | |
| Oct | +3.1% | -1.8% | 40% | +37.2% 2025 | -21.5% 2024 | |
| Nov | -0.5% | -0.8% | 40% | +18.1% 2024 | -19.2% 2021 | |
| Dec | -8.4% | -21.6% | 40% | +43.4% 2023 | -48.9% 2022 |
Methodology#
Monthly returns are total returns (dividends reinvested), computed from IMNM's split- and dividend-adjusted month-end closes. The table shows the most recent 120 months and the bar chart the most recent 60. See the year-by-year returns for the annual view. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Immunome Inc.'s average monthly return?
- Immunome Inc. (IMNM) has averaged about 5.40% per month, positive in roughly 46% of months. The best month was Feb 2021 (+172.4%) and the worst was Dec 2022 (-48.9%).